Through our pharmacogenetic testing we offer you an outstanding opportunity to improve prescribing safety and efficacy by studying the genetic factors that influence your patients’ reactions to particular drugs. This opens the door to personalized medicine by helping you prescribe more efficient treatments based on your patients’ genetic profiles – thereby increasing effectiveness while reducing adverse side effects. Dynacare NEXT is committed to growing this area of genetic testing.
Genecept Assay®: Find the right treatment faster
Finding the right treatment takes time
Despite the availability of effective treatments for many psychiatric illnesses, including mood and anxiety disorders, arriving at the best treatment can still take weeks or months. Patients can become discouraged, discontinue treatments and experience prolonged suffering.
An estimated two-thirds of patients with depression will not respond to first-line treatment, and more than one-third will become treatment-resistant.1-3
The Genecept Assay can shorten the path to finding effective treatments
The Genecept Assay is a genetic test designed to help clinicians optimize treatment decisions and choose medications more likely to be safe and effective.
Identifies variations in 18 key genes relevant to psychiatric treatment that indicate which therapies are likely to work as intended and not result in unwanted side effects or adverse events
Easily administered as a cheek swab test
Every result report includes a complimentary individualized consultation with an expert
The Genecept Assay covers a wide range of psychiatric disorders
Candidates for testing include:
Patients living with:
Obsessive-compulsive disorder (OCD)
Attention deficit hyperactivity disorder (ADHD)
Post-traumatic stress disorder (PTSD)
Autism spectrum disorder
Any patient without optimal treatment response: previously failed treatment trials, poor response or adverse events
Patients with polypharmacy
Patients with psychiatric and medical comorbidities
Patients with medication adherence issues
The Genecept Assay reports are easy to read, understand and share
Three types of test results are possible:
The Genecept Assay report walks you through the genetic results and their treatment implications in detail. The report is easy to explain to patients, and the results help you have productive consultations about treatment with patients and families to improve adherence.
A positive or clinically significant gene result
A negative or non-clinically significant gene result (normal)
An indeterminate gene result (may trigger a retest), or a gene variation of uncertain clinical significance – this result type is rare
Clinical trial results
Studies have shown that using the Genecept Assay has resulted in significant improvements in clinical and economic outcomes.
Measurable clinical improvement, physician-reported4
In a naturalistic study of 685 patients, clinician-rated data using the Clinician Global Impression Improvement scale (CGI-I) showed that:
Measurable patient improvement, patient-reported4
In the same study, patients reported significant:
87% of patients demonstrated a clinically measurable improvement
62% of patients showed a significant clinical improvement (rated much improved or very much improved)
Of the 69% of patients reported as treatment resistant, 91% demonstrated a clinically measurable improvement
Improved patient adherence5
In a retrospective analysis of health claims data, individuals with Genecept Assay-guided treatment were significantly more medication adherent (a 6% increase) than patients with standard treatment.
An expanded panel for greater insight
The Genecept Assay includes:
The Genecept Assay analyzes two types of genes to inform proper treatment:
18 well-characterized, well-annotated genes, extensively supported in peer-reviewed publications to affect treatment for psychiatric conditions
A report with more than 195 citations to the literature
12 pharmacodynamic genes, 6 pharmacokinetic genes
Pharmacodynamic genes indicate the effect a drug has on the body and inform drug candidate selection.
Pharmacokinetic genes indicate the effect the body has on the drug via metabolism and inform drug dosage.
Results in 5 to 8 business days from sample receipt
Ordering the Genecept Assay is simple:
Use the supplied collection kit to obtain a cheek (buccal) swab specimen from your patient.
Your patient’s specimen will be tested upon receipt of the sample at our laboratory, and you will receive a results report within 5 to 8 business days from sample receipt.
Complimentary consultation service
With each Genecept Assay report, Dynacare includes an optional and complimentary expert consultation service, enabling you to consult with a physician or pharmacist to help determine optimal treatment. To schedule a consultation, call 888.988.1888.
To learn more about the Genecept Assay, contact us at 888.988.1888 or DynacareNext@dynacare.ca
Access our Genecept Assay patient brochure
Access our Genecept Assay physician brochure
Access our Genecept Assay White Paper
Access our Genecept Assay Sample Report
Access our Genecept Assay forms
1. Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(suppl 6):16–22.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (ncs-r). JAMA. 2003;289(23):3095–3105.
3. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D project results: A comprehensive review of findings. Curr Psychiatry Rep. 2007;9:449–459.
4. Brennan FX et al. A naturalistic study of the effectiveness of pharmacogenetics testing to guide treatment in psychiatric patients with mood and anxiety disorders. Prim Care Companion CNS Disord. 2015;17(2).
5. Fagerness J et al. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. Am J Manag Care. 2014;20(5):e146–e156.